Skip to content

Clinical trials

Epilepsies, Myoclonic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Myoclonic Country / region: Australia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20162
20182
20191
20212
20223
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Active, not recruiting2
Recruiting2
Available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Longboard Pharmaceuticals5
Takeda4
Encoded Therapeutics3
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2
Bright Minds Biosciences Pty Ltd1
Jazz Pharmaceuticals1
Zogenix, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Myoclonic17
Epilepsy11
Lennox Gastaut Syndrome9
Seizures5
Tuberous Sclerosis4
Brain Diseases3
Neurodevelopmental Disorders2
Central Nervous System Diseases1
Epilepsy, Absence1
Hypoxia-Ischemia, Brain1

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.